secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001493152-25-004161
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Impact Biomedical CEO presents investor slide deck on Jan 29, 2025; no details available
--------------------------------------------------------------------------------

- Slide package furnished as Exhibit 99.1 not included in filing text; no specifics provided.
- CEO Frank D. Heuszel provided investor information on January 29, 2025.
- No financial metrics, guidance, or operational updates disclosed in the filing body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000149315225004161/0001493152-25-004161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000149315225004161/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer